Marc Alessi is a serial entrepreneur and corporate attorney with a focus on the technology startup and healthcare sectors.
Marc is well known for his experience navigating the entrepreneurial ecosystem of Long Island and New York State. He serves as the Executive Director of the Business Incubator Association of New York State and the Tesla Science Center. Marc has helped launch and finance many early stage companies across a variety of industries, including biotechnology, IT, construction, and real estate. A founding member of the Hamptons Angel Network and former Executive Director of the Long Island Angel Network, Marc helped establish Accelerate Long Island.
Marc has a history of public service on Long Island and in New York State. While still a law student, he was appointed as the Downstate Director of Intergovernmental Affairs for the New York State Comptroller’s Office, charged with ensuring that each level of government operated in accordance with state law. Marc was subsequently elected to the New York State Assembly in 2005 and served three terms representing the First Assembly District, which included the Towns of Brookhaven, Riverhead, Southold, and Shelter Island. Marc naturally gravitated toward policy areas that would help create an incentive for investments in startup enterprises in New York State, serving as Chairman of the subcommittee on the emerging workforce as well as a member of the energy, labor, transportation, local government, agriculture, and aging committees and the subcommittee on alternative energy.
Marc lives on Long Island with his wife and their three small children.
State University of New York at Albany, B.A.
Touro College, Jacob D. Fuchsberg Law Center, J.D.
Boards, Associations, and Leadership
Executive Director, Business Incubator Association of New York State, Inc.
Founding Member, Hamptons Angel Network
Member, Past Executive Director, and Past Board of Directors, Long Island Angel Network
Board of Directors, Peconic Bay Medical Center
Member, Advisory Council, East End Arts
Board of Advisors, Nassau-Suffolk Law Services
Former Board of Directors, Long Island Power Authority (LIPA)
2015 – Innovator of the Year Award, Innovate Long Island
2011 – Top 40 Under 40, Long Island Business News
2010 – Man of the Year, Suffolk County Police Conference
2009 – Man of the Year, Long Island Farm Bureau
New Product Development
Yegor D. Sinelnikov, Ph.D. has over 20 years of experience developing medical devices. Specifically, his expertise is in medical acoustic, experimentation, program management and system integration. He brings substantial medical device experience and demonstrated track record of creating innovative technical solution to complex engineering problems, multidisciplinary analyses, and identifying competitive solutions for competing intellectual properties. Dr. Sinelnikov continues research through collaboration in the field on non-linear acoustics and is an author in several issued U.S. patents in the fields of intravascular therapy, atrial fibrillation, tumor ablation, high intensity focused ultrasound and magnetic resonance imaging system integration.
Board of Advisors
Angel investor and active member of the local entrepreneurial ecosystem / community, mentoring, advising entrepreneurs and investing in select startups. Member of New York Angels and board member of Long Island Angel Network.
A seasoned professional in healthcare informatics, transaction processing, relationship marketing and healthcare IT. As a and serial entrepreneur, Mr. Brofman has been a pioneer in the development and adoption of new solutions and systems technology in medical, pharmacy, pharmaceutical and payor components of the healthcare industry. He’s led multiple successful companies, including acquisitions, mergers, and business line consolidations, creating favorable liquidity events for shareholders through sale and exits to strategic buyers
Board of Advisors
With over 20 years of financial technology and global management experience, Kevin serves as Primatics’ Chief Executive Officer. Before Primatics, Kevin served as the Chief Executive Officer of OpenLink Financial. As CEO, Kevin helped transform OpenLink to a multi-national and industry-leading commercial software and professional services organization with more than $300 million in revenue and 1,200 professionals located in nine countries. Previously, Kevin served as OpenLink’s Chief Financial Officer and later as its Chief Operating Officer. Kevin began his career at Ernst & Young LLP, where he ascended to the position of Audit Manager in the specialized privately-owned and emerging business group, providing both audit and business advisory to high growth businesses primarily in the medical technology industry. Kevin has also served as a Chief Financial Officer for two medical technology firms.
Kevin, a native of New York, holds a BS from Fordham University where he graduated valedictorian of the class of 1987.
David Schlyer, Ph.D.
Board of Advisors
A tenured Senior Scientist and Chair of the Medical Department at Brookhaven National Laboratory’s, David Schlyer, Ph.D., has worked on a variety of projects during his more than 30 years at the BNL.
Awarded his B.S. degree in chemistry from the University of California at Riverside in 1971 and his Ph.D. in chemistry from the University of California at San Diego in 1976, Dr. Schlyer then came to BNL’s Chemistry Department as a post-doctoral fellow, to research the development of radioisotope tracers for diagnostic medical imaging.
From 1981 to 1985, Dr. Schlyer worked first as a corporate research chemist and then as chairman of a hospital research department. He returned to Brookhaven Lab in 1985, to continue his work on radioisotope production and to develop new detector and scanning technology for medical imaging.
In addition, Dr. Schlyer is an adjunct professor of biomedical engineering at Stony Brook University and mentors graduate students working towards their Masters and PhD degrees. Working as a consultant for the International Atomic Energy Agency, he trains chemists and physicians who are setting up nuclear medicine programs in developing countries for their citizens’ benefit.
His interests include the cyclotron production of radionuclides, nanoparticle biodistribution and toxicology and the development of new instrumentation for positron emission tomography and magnetic resonance imaging.
Board of Advisors
Burke brings years of successful management and strategic marketing to SynchroPET.
His management career began at ABC Television, directing the midwest region for the owned & operated television stations, as well as directing sales for WABC Television. He designed and executed the growth of six televisions stations and three cable companies for Corinthian Broadcasting, a Dun & Bradstreet Company, as Sr VP Sales & Marketing, exploiting new markets in cable production and syndication.
He is currently Director of Business Strategies and Innovation Development at the College of Business, SUNY Stony Brook.
Board of Advisors
A senior technical and business executive with over 35 years of experience delivering business development, sales and engineering solutions.
Senior member of the technical staff at iSine, Inc. a Long Island based ASIC supplier, specializing in energy and SSL Solid State Lighting solutions.
Bob has built World Wide Application groups and engineering departments for Ungerman and Bass, Standard Microsystems Corporation (SMC) and Reuters all here on Long Island. He has developed strategic relationships with: IBM, Intel, Dell, HP, BAE and Sylvania just to name a few.
Bob is also active as a Consulting Partner at Lighting Solution Development, “Market Intelligence for Lighting Developers”, is on the advisory board at Synchropet and also a consulting sales partner at UMS, Universal Management Solutions.
Bob holds a Bachelor of Engineering with minor in Fine Arts from SUNY Stony Brook. He is a member of the LICA, ODNLI, IEEE, IMAPS and SMTA. He has 2 patents and several publications.
Tom has led or been on great teams that have given us the video game, handheld game, microcontroller, auto electronics, and medical device industries. In the process of 400 embedded control and software/firmware products and nine patents, he has helped lay the groundwork and commercialized fields as diverse as speech synthesis and recognition, wireless and wired data networking, and artificial intelligence.
Among the “firsts” are technology for healthcare systems for countries, annual reports for the hotel and hospital industry associations, nationwide banking systems, monitoring systems for the US Telcom Industry, mainframe and embedded real-time operating systems, and the first use of Windows in embedded control development systems.
The past decade has yielded helping found, grow to nine-figure annual sales, and exit a medical device company that grew to dominate its market as the developer, manufacturer, and worldwide seller of medical imaging systems. This has jelled the experiences into the determination, leadership, project management, and industry and regulatory knowledge needed to turn a great idea into a shipping product from a great company.
But the proudest results come from helping amazing team members organize, finance, create, support, and sell industry-leading technical products while getting them the rewards they earn.